Plasma vascular endothelial growth factor in acute mountain sickness

Chest

Volumn 118, Issue 1, 2000, Pages 47-52

  Maloney, James ^a   Wang, Dale ^d   Duncan, Timothy ^e   Voelkel, Norbert ^b   Ruoss, Stephen ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Boulder Community Hospital   (United States)

^e St Clare s Hospital   (United States)

Author keywords

Acute mountain sickness; Endothelial permeability; High altitude pulmonary edema; Vascular endothelial growth factor

Indexed keywords

ACETAZOLAMIDE; VASCULOTROPIN;

ADULT; ALTITUDE DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUNTAINEERING; OXYGEN AFFINITY; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

EID: 0033914877     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.1.47     Document Type: Article

References (32)

1. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993; 118:587-592
2. Hansen JM, Olsen NV, Feldt-Rasmussen B, et al. Albuminuria and overall capillary permeability of albumin in acute altitude hypoxia. J Appl Physiol 1994; 76:1922-1927
3. Kleger GR, Bartsch P, Vock P, et al. Evidence against an increase in capillary permeability in subjects exposed to high altitude. J Appl Physiol 1996; 81:1917-1923
4. Kaminsky DA, Jones K, Schoene R, et al. Urinary leukotriene E4 levels in high-altitude pulmonary edema. Chest 1996; 110:939-945
5. Richalet JP, Hornych A, Rathat C, et al. Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir Physiol 1991; 85:205-215
6. Xu F, Severinghaus JW. Rat brain VEGF expression in alveolar hypoxia: Possible role in high-altitude cerebral edema. J Appl Physiol 1998; 85:53-57
7. Grissom CK, Zimmerman GA, Whatley RE. Endothelial selectins in acute mountain sickness and high-altitude pulmonary edema. Chest 1997; 112:1572-1578
8. Westerterp KR, Robach P, Wouters L, et al. Water balance and acute mountain sickness before and after arrival at high altitude of 4,350 m. J Appl Physiol 1996; 80:1968-1972
9. Hackett P. The cerebral etiology of high-altitude cerebral edema and acute mountain sickness. Wilderness Environ Med 1999; 10:97-109
10. Severinghaus J. Hypothesis: Angiogenesis cytokines in high altitude cerebral edema. Acta Anaesth Scan 1995; 39:177-178
11. Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3:211-220
12. Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114:521-532
13. Maloney JP, Ambruso DR, Silliman CS, et al. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol (Heart Circ Physiol) 1998; 275:H1054-H1061
14. Murohara T, Horowitz JR, Silver M, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998; 97:99-107
15. Collins PD, Connolly DT, Williams TJ. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 1993; 109:195-199
16. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108:2369-2379
17. Wang W, Merrill MJ, Borchardt RT. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol 1996; 271(6 Pt 1):C1973-C1980
18. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Nad Acad Sci USA 1998; 95:15809-15814
19. Christou H, Yoshida A, Arthur V, et al. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1998; 18:768-776
20. Hayashi T, Abe K, Suzuki H, et al. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 1997; 28:2039-2044
21. Strugar JG, Criscuolo GR, Rothbart D, et al. Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 1995; 83:682-689
22. Klekamp JG, Jarzecka K, Hoover RL, et al. Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone. Pediatr Res 1997; 42:744-749
23. Hackett PH, Roach RC, Wood RA, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 1988; 59:950-954
24. Hackett P, Oelz O. The Lake Louise consensus on the definition and quantification of altitude illness. In: Sutton J, Coates G, Houston C, eds. Hypoxia and Mountain Medicine. Burlington, VT: Queen City Printers, 1992; 327-330
25. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer. Br J Cancer 1998; 77:956-964
26. Johnson TS, Rock PB. Acute mountain sickness. N Engl J Med 1988; 319:841-844
27. Gunga H, Kirsch K, Rocker L, et al. Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol 1999; 79:484-490
28. Ferrari G, Scagliotti GV. Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients [letter]. Eur J Cancer 1996; 32A:2368-2369
29. Harada M, Mitsuyama K, Yoshida H, et al. Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 1998; 27:377-380
30. Crew JP, O'Brien T, Bicknell R, et al. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol 1999; 161:799-804
31. Levine BD, Yoshimura K, Kobayashi T, et al. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1989; 321:1707-1713
32. VEGF ELISA Kit Manual DVE00. Minneapolis, MN: R&D Systems, 1998